Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.

By L. Bruni, Mireia Díaz, X. Castellsagué, E. Ferrer, F. Bosch, S. de Sanjosé. Journal of Infectious Diseases, 2010

1,633 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Global cancer statistics, 2012 (2015, background): “HPV infection prevalence (all types) varies widely, from as high as 21% in Africa and 16% in Latin America and the Caribbean to 9% in Asia and 5% in Northern America.(92) In several Western countries, where screening programs have long been established, cervical cancer rates have decreased by as muc”
Global Cancer Incidence and Mortality Rates and Trends—An Update (2015, background): “HPV infection prevalence ranges from 5% in North America to 21% in Africa (95).”
Human papillomavirus molecular biology and disease association (2015, background): “((and men) 50–80% [36]) and declines in older age groups [37].”
Global burden of human papillomavirus and related diseases. (2012, background): “aRegionally-adjusted HPV (see [1] for adjustment methodology).”